Tech Company Financing Transactions
Advanced Cell Technology Funding Round
Advanced Cell Technology closed a $400 thousand funding round on 3/4/2009. Investors included CHA Biotech.
Transaction Overview
Company Name
Announced On
3/4/2009
Transaction Type
Venture Equity
Amount
$400,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from these transactions as well as other transactions in advanced discussions will be used to support the Company's retinal pigment epithelium cells (RPE) program.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Marlborough, MA 01605
USA
Marlborough, MA 01605
USA
Phone
Undisclosed
Website
Email Address
Overview
Advanced Cell Technology is focused on developing and commercializing human embryonic and adult stem cell technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ted Myles
Chief Scientific Officer
Robert Lanza
VP - Bus. Development
Matthew Vincent
VP - Manufacturing
Roger Gay
Browse more venture capital transactions:
Prev: 3/3/2009: 1Life Healthcare venture capital transaction
Next: 3/4/2009: Onset Technology venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to document every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs